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ABSTRACT
Study queStion
Is stepped care compared with usual care effective in 
preventing the onset of major depressive, dysthymic, 
and anxiety disorders in older people with visual 
impairment (caused mainly by age related eye disease) 
and subthreshold depression and/or anxiety?
MethodS
265 people aged ≥50 were randomly assigned to a 
stepped care programme plus usual care (n=131) or 
usual care only (n=134). Supervised occupational 
therapists, social workers, and psychologists from low 
vision rehabilitation organisations delivered the 
stepped care programme, which comprised watchful 
waiting, guided self help based on cognitive 
behavioural therapy, problem solving treatment, and 
referral to a general practitioner. The primary outcome 
was the 24 month cumulative incidence (seven 
measurements) of major depressive dysthymic and/or 
anxiety disorders (panic disorder, agoraphobia, social 
phobia, and generalised anxiety disorder). Secondary 
outcomes were change in symptoms of depression and 
anxiety, vision related quality of life, health related 
quality of life, and adaptation to vision loss over time 
up to 24 months’ follow-up.
Study anSwer and liMitationS 
62 participants (46%) in the usual care group and 38 
participants (29%) from the stepped care group 
developed a disorder. The intervention was associated 
with a significantly reduced incidence (relative risk 
0.63, 95% confidence interval 0.45 to 0.87; P=0.01), 
even if time to the event was taken into account 
(adjusted hazard ratio 0.57, 0.35 to 0.93; P=0.02). The 
number needed to treat was 5.8 (3.5 to 17.3). The 
dropout rate was fairly high (34.3%), but rates were not 
significantly different for the two groups, indicating 
that the intervention was as acceptable as usual care. 
Participants who volunteered and were selected for 
this study might not be representative of visually 
impaired older adults in general (responders were 
significantly younger than non-responders), thereby 
reducing the generalisability of the outcomes.
what thiS Study addS 
Stepped care seems to be a promising way to deal with 
depression and anxiety in visually impaired older 
adults. This approach could lead to standardised 
strategies for the screening, monitoring, treatment, 
and referral of visually impaired older adults with 
depression and anxiety.
Funding, CoMpeting intereStS, data Sharing
Funded by ZonMw InZicht, the Dutch Organisation for 
Health Research and Development-InSight Society. 
There are no competing interests. Full dataset and 
statistical code are available from the corresponding 
author.
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Introduction
Impaired vision is an important cause of age related dis-
ability; 285 million people globally are visually 
impaired, of whom 65% are aged ≥50.1  Depression and 
anxiety are common health problems in visually 
impaired older adults, whose loss of vision is caused 
mainly by age related disease such as age related macu-
lar degeneration and glaucoma. About a third experi-
ence subthreshold depression and/or anxiety 
(indicating clinically significant symptoms, but no 
actual disorder).2-5  About 7% are diagnosed with an 
anxiety disorder and 5-7% with a major depressive dis-
order, according to the Diagnostic and Statistical Man-
ual of Mental Disorders, fourth edition (DSM-IV).5-7 
These percentages are substantially higher than the 
prevalence in the general elderly population.8 9  Both 
disorders can have a detrimental impact on visually 
impaired older adults, leading to increased vision spe-
cific disability, decreased quality of life, a decline in 
health status, and even mortality.4 10-12  Care providers, 
however, underestimate the negative effects of loss of 
vision on mental health, standard procedures are miss-
ing, and patients often do not perceive a need for pro-
fessional mental health services.10 13 Hence, detection of 
depression and anxiety is poor, and treatment is often 
lacking.
Systematic reviews show that some studies have 
found that effective psychological interventions—
such as self management programmes and problem 
solving treatment—can reduce depression in visually 
impaired older adults.10 14  These reviews suggest that 
WhAT IS AlReAdy knoWn on ThIS TopIC
Previous studies have shown short term effective results in diminishing depression 
in visually impaired older adults by offering psychological interventions, such as 
problem solving treatment and self management programmes
Evidence is scarce, especially concerning treatment of anxiety, and long term 
effective results are lacking
WhAT ThIS STudy AddS 
Stepped care, in which treatment components were combined and offered only 
when necessary over a period of one year, was effective in reducing both 
depression and anxiety in visually impaired older adults, even after a follow-up of 
two years.
Investigating stepped care in this population was novel and could lead to standard 
trajectories to deal with depression and anxiety in visually impaired older adults
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 psychological interventions can be incorporated into 
low vision rehabilitation because functional ability 
and depression are closely related in this group. In 
addition, effects of psychological interventions have 
been studied only up to six months,10 14  while longer 
term efforts to monitor and prevent depression and 
anxiety might be needed. Visually impaired older 
adults are likely to face further physical decline over 
time (eye diseases are often degenerative), which can 
lead to an increased risk of depression and anxiety.10
Several studies outside the specialty of low vision 
found that stepped care service delivery models, 
designed to delay or prevent the onset of depression and 
anxiety in people who show early symptoms, can be 
effective.15  Stepped care aims to meet the need for long 
term management of the disease and maximise the 
effectiveness and efficiency of resource allocation. Sub-
sequent treatment components are offered by order of 
intensity—that is, patients start with low intensity inter-
ventions and move on to higher intensity interventions 
only when a sufficient response is lacking. Progress is 
monitored throughout the entire process.15  Current mul-
tidisciplinary guidelines for mental healthcare in the 
Netherlands and the National Institute for Health and 
Care Excellence (NICE) in the United Kingdom recom-
mend using a stepped care model to approach depres-
sion in older adults.16 17 Stepped care, however, has not 
been investigated in older adults with chronic visually 
impairment, who experience specific difficulty in adjust-
ing to their disability. Taking into account the high prev-
alence of depression and anxiety in this population and 
the possibilities of a long term preventive approach, we 
investigated the effectiveness of a population specific 
stepped care programme to prevent the onset of major 
depressive, dysthymic, and anxiety disorders. In addi-
tion, we determined the effects on reducing symptoms 
of depression and anxiety and improved adaptation to 
vision loss and quality of life. We hypothesised that 
stepped care, incorporated in low vision rehabilitation 
care, would be more effective than usual care alone.
Methods
Study design
This study was a single masked international multicentre 
randomised controlled trial, exactly as described in the 
original protocol.18 Participants were individually ran-
domised in the ratio 1:1 to one of two parallel groups—
that is, to usual care or stepped care plus usual care.
participants
Between July 2012 and April 2013, 3000 patients aged 
≥50 from outpatient low vision rehabilitation organisa-
tions in the Netherlands and Belgium were contacted 
by letter and telephone and asked to participate. Of 
these, 914 provided written informed consent (response 
rate 30%). Participants were allowed to withdraw their 
consent for any reason at any time during the study. 
Baseline interviews with responders were performed to 
determine eligibility.
The organisations follow the World Health Organiza-
tion criteria for eligibility, which are described in the 
Dutch guideline “Vision disorders, rehabilitation and 
referral.”19  This guideline dictates that all patients 
should have a decimal visual acuity of ≤0.3 and/or a 
visual field of ≤30° around the central point of fixation 
and/or an evident request for help for which options in 
regular ophthalmic practice are not adequate, such as 
contrast sensitivity or glare. Additional inclusion crite-
ria were having subthreshold depression and/or anxi-
ety—that is, a score of  ≥8 on the hospital anxiety and 
depression scale-anxiety subscale (HADS-A)20 21  and/or 
≥16 on the Centre for Epidemiologic Studies depression 
scale (CES-D)22 23 ; not meeting the diagnostic criteria of 
a major depressive, dysthymic, and/or anxiety disorder 
according to the DSM-IV (measured with the Mini Inter-
national Neuropsychiatric Interview (MINI))24 25 ; being 
able to speak the Dutch language adequately; and not 
being severely cognitively impaired (measured with a 
six item screen, a short version of the mini-mental state 
examination, MMSE).26  Additional details on inclusion 
criteria and protocol design are described elsewhere.18
patient involvement
Patients (n=8) from low vision rehabilitation organisa-
tions were involved in the development and implemen-
tation of the stepped care programme based on two 
focus group meetings in the Netherlands and Belgium. 
Patients were not involved in determining study con-
duct, recruitment, and design. The burden of the inter-
vention and participation in the study in general was 
assessed by a panel of patient representatives, which 
was assigned by the funding agency. The burden of the 
intervention was not assessed as such by participating 
patients but satisfaction with the intervention was. 
Results of the study will be disseminated by letter to all 
participants by the end of 2015.
randomisation and masking
Our prespecified power calculation was based on the 
study of van ‘t Veer and colleagues,27  who found the 
proportion of people developing a disorder to be 0.4 in 
the control group and 0.2 in the intervention group, 
with a relative risk of 0.5, leading to an effect size of 
2*arcsine(√0.2)−2*arcsine(√0.4)=0.44. In addition, we 
used α≤0.05 (two sided), power 0.85, and dropout rate 
20%, which showed that we needed a minimum of 230 
patients (115 in each arm).18 As dropout rates observed 
at the start of the trial were higher than expected, we 
recruited more patients (n=265). Patients were assigned 
to usual care or the stepped care programme in addition 
to usual care. A computerised random number genera-
tor produced the allocation scheme. The scheme was 
based on blocks of two and stratified by 17 locations of 
three outpatient low vision rehabilitation organisations 
in the Netherlands and Belgium. An independent 
researcher carried out the randomisation after the base-
line measurement. Patients were registered as being a 
participant of this study in their records at the rehabili-
tation centres. Only when guidance needed to be 
offered in step two or three of the programme were the 
clinical staff directly informed by the independent 
researcher as to which patient to treat.
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Data were collected from September 2012 to July 2015, 
during which seven measurements took place (at base-
line and at 3, 6, 9, 12, 18, and 24 months) by means of 
telephone interviews. These were performed at the VU 
University Medical Centre by masked research assis-
tants, who were trained to diagnose depressive and 
anxiety disorders and follow a prespecified protocol. At 
the outset of the study and at the start of each telephone 
interview participants were told not to divulge the 
nature of their treatment during the telephone inter-
views. We checked if masking was maintained by ask-
ing research assistants to guess which treatment arm 
was offered. They were right in 38% of the cases, indi-
cating that masking was effective. To minimise the pos-
sibility of data entry errors, the research assistants used 
specially designed data entry software (Blaise) to record 
all measurements. Because of the nature of the inter-
vention, the participants and therapists could not be 
masked.
interventions
The stepped care programme was based on a model 
similar to that previously used in the general elderly 
population and shown to be effective.27 28  The pro-
gramme was altered and tailored to the needs of people 
with vision impairment based on a focus group with 
social workers and psychologists from the low vision 
rehabilitation organisations (n=12) and two focus 
groups with patient representatives (n=8). Specific 
attention was given to the difficulty of adjusting to 
vision loss and the physical and psychological conse-
quences of this impairment (such as bereavement, 
fatigue, psychosocial adjustment) that could lead to 
feelings of depression and anxiety. Exercises and exam-
ples were altered and added based on direct input of 
patients and professionals. Specific attention was also 
given to the manner in which the programme was 
offered (for example, audio and Braille version of writ-
ten documents). Additional information on programme 
development is provided elsewhere.18
The final programme contained four consecutive 
steps that took about three months each: watchful wait-
ing, guided self help based on cognitive behavioural 
therapy, problem solving treatment, and referral to the 
general practitioner (GP) (box). All treatments were 
offered individually. Only when patients still had 
increased symptoms of depression and/or anxiety 
(score of ≥8 on the HADS-A and/or ≥16 on the CES-D) 
could they move on to the next step. A score below the 
cut-off point resulted in a (longer) period of watchful 
waiting until an increased score indicated the need for 
the next step of the programme. Therefore, not all 
patients of the stepped care group completed all steps 
of the intervention. Patients were seen at the rehabilita-
tion centre or at home, based on the patient’s prefer-
ence. Patients in both the stepped care and usual care 
group who developed a major depressive, dysthymic, 
and/or anxiety disorder, were directly referred to their 
GP to discuss further treatment. Usual care in both the 
treatment and control group included outpatient low 
vision rehabilitation care and/or care that was provided 
by other healthcare providers.
outcome measures
The primary outcome measure of this study was the inci-
dence of major depressive, dysthymic, and/or anxiety 
disorders (panic disorder, agoraphobia, social phobia, 
and/or general anxiety disorder) according to the 
DSM-IV, for which the Dutch MINI Plus (5.0.0), developed 
Stepped care treatment protocol for visually impaired older adults
Step 1 watchful waiting (three months)
•	The first step was a period of watchful waiting, involving an active decision not to 
treat the condition but, instead, to intermittently reassess its status
•	The executive researcher contacted the patient by telephone at baseline (for about 
15 minutes) and after three months of watchful waiting (for about 15 minutes)
•	Patients could contact the executive researcher by telephone during this period if 
necessary
Step 2 guided self help (three months)
•	 In the second step, guided self help, based on a written, digital, audio, and Braille 
version of a self help course based on cognitive behavioural therapy (with specific 
vision related examples and exercises), was offered. The course was divided into 
seven chapters, aimed at:
•	 Increasing awareness of depression and anxiety in relation to having a chronic 
visual impairment, and setting a personal goal
•	 Increasing awareness of fatigue and stress in relation to depression and anxiety 
in people with a visual impairment, and offering relaxation exercises
•	 Increasing awareness of pleasurable activities that can still be carried out despite 
the visual impairment, and encouragement to take action
•	 Identifying and replacing self defeating thoughts with healthier thoughts by 
means of exercises based on rational emotive behaviour therapy
•	 Identifying negative thought patterns (for example, black and white thinking, 
catastrophic thinking) and replace unhelpful thoughts with helpful thoughts
•	 Identifying personal communication styles (passive, assertive, or aggressive), and 
learning to use an assertive communication style
•	Continuing to use learned skills by reflecting on everything that has been learnt 
and setting goals for the future
•	Guidance was provided by trained and supervised occupational therapists (n=17) 
from the outpatient low vision rehabilitation organisations. Two face to face 
contacts took place at the beginning of the intervention (about 60 minutes each 
contact) and one to three telephone calls (for about 15 minutes each). In the 
meantime patients followed the intervention at home
Step 3 problem solving treatment (three months)
•	 In the third step trained and supervised social workers (n=7) and psychologists 
(n=5) from the low vision rehabilitation centres offered problem solving treatment 
•	A maximum of seven face to face contacts (about 60 minutes each) took place
•	During each of these contacts the seven steps of problem solving treatment were 
completed:
•	Clarify the problem
•	Establish realistic goals
•	Generate multiple alternative solutions by brainstorming
•	Explore pros and cons of the alternative solutions
•	Select the best solution
•	Conduct a plan to carry out the best solution
•	Evaluate the process
Step 4 referral to a gp
•	When increased symptoms of depression and anxiety still persisted after problem 
solving treatment, the executive researcher contacted the patient by telephone to 
refer him or her to their GP (about 15 minutes)
•	The executive researcher called the GP, who made an appointment with the patient 
to discuss further treatment and the use of drug treatment (about 15  minutes)
doi1 02.00;h/bmj.hh0 27 | BMJ   2015;101hh0 27 | the bmj
RESEARCH
4
in clinician rated format (MINI-CR), was used at baseline 
and at 3, 6, 9, 12, 18, and 24 months in both groups. The 
MINI is a brief structured interview developed to diag-
nose psychiatric disorders according to DSM-IV criteria. 
It is considered a valid and reliable tool to define mental 
disorders based on a 20 minute telephone interview.24 25 
The MINI shows moderate to high κ coefficients for all 
diagnoses, except for generalised anxiety disorder for 
which the κ is just below 0.5.24 25 Although a dysthymic 
disorder requires a depressed mood for over two years 
(not interrupted by more than two months at a time), it 
was included in the outcome measure because partici-
pants who were not diagnosed with a dysthymic disor-
der at one time point (for example, they had experienced 
a depressed mood only for the past 1.5 years) could be 
diagnosed with this disorder by the next time point. 
History of major depressive, dysthymic, and panic dis-
order at baseline was also determined with the MINI.
Secondary outcome measures were symptoms of 
depression and anxiety measured with the CES-D and 
HADS-A at baseline and at 3, 6, 9, 12, 18, and 24 months. 
The CES-D is a 20 item scale with a total score ranging 
from 0-60 and a cut-off score for subthreshold depres-
sion and/or anxiety of ≥16. It is a widely used scale and 
considered a valid and reliable instrument to measure 
symptoms of depression and anxiety in older adults.22  23 
The HADS-A, also used to measure symptoms of anxiety, 
has seven items, with a total score ranging from 0-21 and 
a cut-off score for subthreshold anxiety of ≥8. Its reliabil-
ity is reported to be “good to very good” in older adults.20  21 
In addition, vision related quality of life was measured 
with the low vision quality of life questionnaire (LVQOL, 
with 21 questions on a 6 point Likert scale, measuring 
the disability experienced by patients in daily life),29  30 
and adaptation to vision loss was measured with the 
adaptation to vision loss (AVL) scale (adapted from the 
AVL-12,31 with nine questions on a 4 point Likert scale, 
measuring intrapersonal and interpersonal acceptance 
of vision loss) at baseline and after 12 and 24 months. 
Psychometric properties of these questionnaires were 
investigated with item response theory models. We 
found no evidence of multidimensionality, local depen-
dence, or differential item functioning, and all scales 
showed good fit to the model (that is, graded response 
model), except the HADS-A. Three items from the LVQOL 
were deleted to resolve local dependence, leading to the 
unidimensional LVQOL-18.
Health related quality of life was measured at base-
line and after 12 and 24 months with the Euroqol-5 
Dimensions (EQ-5D, which consists of five dimensions 
of functional impairment: mobility, self care, usual 
activities, pain/discomfort, and depression/anxiety).32 
We used utility scores based on the Dutch tariff, where 1 
denotes full health and 0 means a health state compa-
rable with death (range −0.58 to 1, where negative utili-
ties are valued as worse than death).32
For the process evaluation, firstly we measured compli-
ance with treatment in step two and three of the pro-
gramme based on the number of patients who rejected 
the intervention and the number and duration of appoint-
ments. Secondly, we reviewed therapist adherence to the 
problem solving treatment protocol based on audiotapes 
of a random selection of sessions (n=13). Thirdly, we 
determined adoption of the interventions based on thera-
pists’ experiences, measured with two questions (“Are 
you satisfied with the results of the intervention?” and 
“Do you think the intervention suited the needs of the 
patient?”) and patients’ evaluation of the services, mea-
sured with the Dutch mental healthcare thermometer of 
satisfaction, a widely used 20 item questionnaire.33
We used the Trimbos/iMTA questionnaire for costs 
associated with psychiatric illness (TicP)34  to measure 
usual care at 6, 12, 18, and 24 months. This question-
naire measured self reported use of healthcare based on 
the number of contacts with a GP, company physician, 
medical specialist, physiotherapist or occupational 
therapist, social worker, psychologist or psychiatrist, 
alternative healer, homecare, guided group based peer 
support, admission to hospital, and use of drugs in the 
past six months.34  At baseline we used the perceived 
need for care questionnaire (PNCQ) to determine mental 
health services received in three months before the start 
of the study. This measured received information about 
mental illness and treatment possibilities, practical sup-
port, skills training, counselling/therapy, and drugs.35
Decimal visual acuity was retrieved from patient files 
at the low vision rehabilitation centres; missing values 
(n=22) were supplemented with estimates of visual acu-
ity provided by self report based on recent ophthalmic 
diagnostics. To enable meaningful computations, these 
values were transformed to logMAR values (−log10 
visual acuity), where a visual acuity of 0.00-0.29 rep-
resents normal vision, 0.30-0.51 mild vision loss, and 
0.52-2.00 low vision or blindness.
Patients were asked about comorbidity based on 
eight major condition groups: peripheral arterial dis-
ease, asthma or chronic obstructive pulmonary disease, 
diabetes mellitus, osteoarthritis and rheumatoid arthri-
tis, cerebrovascular event or stroke, cardiac disease, 
cancer, and other chronic conditions. Compared with 
GP information, the accuracy of the self reports of these 
diseases was shown to be adequate and independent of 
cognitive impairment.36
data analysis
We used SPSS for Windows version 20 (SPSS IBM, New 
York, USA) to perform an intention to treat analysis. 
Firstly, we tested differences in patients’ characteristics 
in the stepped care and usual care group, and in 
patients who dropped out and those who completed the 
follow-up period, for consistency based on indepen-
dent sample t tests and χ² tests. Secondly, we deter-
mined the absolute and relative risk of developing a 
depressive and/or anxiety disorder in the usual care 
versus the stepped care plus usual care group and the 
number needed to treat as the inverse of the risk differ-
ence. Thirdly, we carried out a survival analysis based 
on a Kaplan-Meier curve, log rank test, and (adjusted) 
Cox proportional hazard regression analysis to compare 
differences between the stepped care and usual care 
groups in time to the onset of a depressive and/or anxi-
ety disorder. We chose survival analysis because time 
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played an important role in the present study as the pro-
gramme aimed to delay or prevent the onset of a depres-
sive and/or anxiety disorder. Fourthly, to investigate the 
effect of the intervention on the secondary outcomes, 
we performed linear mixed models using maximum 
likelihood estimation. Follow-up measurements of the 
secondary outcomes were adjusted for their baseline 
value. The intervention effect was defined as the inter-
action of treatment allocation (stepped care v usual 
care) by time (follow-up until 24 months).
Results
participants
Non-responders (n=2086) were significantly older than 
responders (n=914, mean difference 4.6 years, P<0.001); 
no significant difference in sex was found. Baseline 
interviews resulted in the exclusion of 519 responders 
who had no symptoms of depression/anxiety, 124 who 
had a depressive/anxiety disorder, and six who were 
cognitively impaired. The 265 remaining eligible partic-
ipants were randomised to either the stepped care 
group (n=131) or the usual care group (n=134). Of these, 
91 participants were lost to follow-up after 24 months 
(34%); 45 in the stepped care group and 46 in the usual 
care group (fig 1). Those who dropped out of the study 
were significantly older and more lived in a nursing 
home than those who were not lost to follow-up 
(P<0.05). The most common reasons for loss to fol-
low-up were death (16% of stepped care and 24% of the 
usual care group), physically or mentally not able to 
continue (18% and 22%, respectively), and too great a 
burden to continue (18% and 17%, respectively).
In the stepped care group, all 131 participants 
received a period of watchful waiting, 73 (56%) received 
guided self help, 29 (22%) received problem solving 
treatment, and seven (5%) were referred to their GP 
(table 1 ). Patients who did not move on to the next step 
of the programme either no longer had subthreshold 
symptoms of depression and/or anxiety or had devel-
oped a full blown depression and/or anxiety disorder 
and were immediately referred to their GP. There was no 
significant difference between the stepped care and 
usual care group in baseline characteristics of patients 
(table 2 ) and use of healthcare (table 3), except for level 
of education (P<0.05).
effectiveness
During the 24 month follow-up, 38 (29%) of the 131 par-
ticipants in the stepped care group and 62 of the 134 
participants (46%) in the usual care group developed a 
major depressive, dysthymic, and/or anxiety disorder. 
The absolute difference was 17% (95% confidence inter-
val 13 to 22). The stepped care programme was associ-
ated with a significantly reduced incidence of 
depressive and anxiety disorders, with a relative risk of 
0.63 (0.45 to 0.87; P=0.01). The number needed to treat 
(as an inverse of the absolute risk difference, 1/0.17) was 
5.8 (3.5 to 17.3), indicating the average number of 
patients who needed to be treated to prevent one addi-
tional depressive or anxiety disorder. Of the 38 patients 
who developed a disorder in the stepped care group, 19 
had a history of major depressive, dysthymic, and/or 
panic disorder (50%) compared with 18 of the 62 
patients in the control group (29%). This difference was 
significant (χ²=4.4, P=0.04). Mental health services 
used in the past for people who developed a disorder 
during this trial were not significantly different for the 
stepped care and usual care group.
The Kaplan-Meier curve and the log rank test showed a 
significant difference in time to the onset of a depressive 
and/or anxiety disorder between the stepped care and 
usual care group (fig 2, χ²=8.2, P=0.004).  Cox  regression 
Allocated to usual care (n=134)Allocated to stepped care (n=131)
3 month follow-up (n=122)3 month follow-up (n=124)
6 month follow-up (n=109)6 month follow-up (n=108)
9 month follow-up (n=106)9 month follow-up (n=103)
12 month follow-up (n=102)12 month follow-up (n=98)
18 month follow-up (n=95)18 month follow-up (n=85)
24 month follow-up (n=88)24 month follow-up (n=86)
Complete data over time (n=131) Complete data over time (n=134)
Invited by letter and telephone (n=3000)
Screened for eligibility (n=914)
Randomised (n=265)
Excluded (n=649):
  No depression/anxiety symptoms (n=519)
  Depressive and/or anxiety disorder (n=124)
  Cognitively impaired (n=6)
Non-response (n=2086)
No show (n=5)
Dropped out (n=7)
  Refused (n=11)
  Died (n=1)
No show (n=1)
Dropped out (n=4)
  Refused (n=4)
  Died (n=1)
No show (n=2)
Dropped out (n=3)
  Refused (n=4)
  Cognition (n=1)
No show (n=2)
Dropped out (n=3)
  Refused (n=6)
  Cognition (n=1)
No show (n=5)
Dropped out (n=10)
  Refused (n=14)
  Died (n=1)
No show (n=2)
Dropped out (n=7)
  Refused (n=7)
  Died (n=2)
Dropped out (n=9)
  Refused (n=5)
  Cognition (n=2)
  Died (n=2)
No show (n=2)
Dropped out (n=16)
  Refused (n=13)
  Died (n=5)
No show (n=1)
Dropped out (n=15)
  Refused (n=15)
  Died (n=1)
Dropped out (n=7)
  Refused (n=5)
  Died (n=2)
No show (n=2)
Dropped out (n=4)
  Refused (n=6)
Dropped out (n=4)
  Refused (n=1)
  Died (n=3)
Fig 1 | Flow of participants in study of stepped care for depression and anxiety in visually 
impaired older adults
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analysis showed a crude hazard ratio of 0.59 (95% confi-
dence interval 0.38 to 0.91; P=0.02) and an adjusted haz-
ard ratio of 0.57 (0.35 to 0.93; P=0.02, adjusted for centre 
and baseline patient characteristics described in table 2). 
The proportional hazard assumption was met.
We observed significant intervention effects after 24 
months for the CES-D (group difference −0.57, 95% con-
fidence interval −1.04 to −0.10; P=0.02), the HADS-A 
(−0.21, −0.41 to −0.01; P=0.04), and the LVQOL-18 (3.81, 
0.65 to 6.96; P=0.02) in favour of stepped care. There 
were no significant intervention effects, however, for 
the AVL-9 (0.19, −1.13 to 1.51; P=0.8) and the EQ-5D (0.02, 
−0.05 to 0.09; P=0.6). Table 4 shows the observed mean 
summary scores for the secondary outcomes per mea-
surement for the stepped care and usual care group.
process evaluation
Out of 73 patients who were eligible for guided self help, 
six refused and 12 only partly received it. Out of 29 
patients who were eligible for problem solving treat-
ment, five refused and four only partly received it. The 
main reasons were that participants did not believe this 
kind of help was necessary (37%) and it was too great a 
burden to follow the intervention (28%). In four cases, 
patients received more help with the self help course 
than planned in the protocol—for instance, one patient 
received an additional face to face and telephone con-
tact, and four patients received an additional telephone 
contact. On average 5.33 (range 2-11) sessions of problem 
solving treatment took place. In two patients, the thera-
pist offered more support than the planned maximum of 
seven sessions (one patient received eight and another 
patient received 11 sessions). Audiotapes showed fidelity 
to the problem solving treatment  protocol. In two cases, 
however, steps could not be completed during one ses-
sion; they were then finished in another session.
Occupational therapists were satisfied with the result 
of the self help course in 73% of the cases and thought 
the intervention suited the needs of patients in 71% of 
the cases. Social workers and psychologists were also 
often satisfied with the result (68%) and believed that 
problem solving treatment suited the needs of patients 
(63%). Table 5 presents information on patient evalua-
tion of services. Lower satisfaction scores were not asso-
ciated with the development of depressive and/or 
anxiety disorders after 24 months of follow-up 
(Mann-Whitney U test, guided self help, P=0.6; problem 
solving treatment, P=0.7).
discussion
Compared with usual care, in this study stepped care 
had a significant preventive effect on the development 
of depressive and anxiety disorders in older adults with 
visual impairment (caused mainly by age related eye 
disease) over a two year period (adjusted hazard ratio 
0.57) and significantly reduced symptoms of depression 
and anxiety and improved vision related quality of life. 
These outcomes resemble those from another study that 
showed a stepped care programme for older adults (age 
≥75) in the general population was effective in prevent-
ing depressive and anxiety disorders.27 28 This is an 
important outcome considering the serious conse-
quences of these disorders in visually impaired older 
adults and the previous absence of long term treatment 
effects. Prevention of these disorders will have a posi-
tive impact on many different aspects of patients’ lives 
and could lead to a reduction of societal costs (such as 
healthcare costs and productivity).
We combined treatment components and monitored 
patients over a two year period by offering support only 
table 1 | uptake of different steps of stepped care programme for depression and anxiety 
in visually impaired older adults in intervention group (n=131) over 12 months. Figures 
are numbers (percentage) of participants
treatment components
0-3 months 
(n=131)
3-6 months 
(n=124)
6-9 months 
(n=108)
9-12 months  
(n=98)
total  
(0-12 months) 
(n=131)
Watchful waiting 131 (100) — — — 131 (100)
Guided self help — 58 (47) 14 (13) 1 (1) 73 (56)
Problem solving treatment — — 18 (17) 11 (11) 29 (22)
Referral to general practitioner — — 7 (7) 7 (5)
table 2 | patients’ characteristics measured at baseline in intervention group (n=131; 
stepped care programme for depression and anxiety in visually impaired older adults) 
and control group (n=134, usual care). Figures are numbers (percentage) of participants 
unless stated otherwise
intervention  
group (n=131)
Control group 
(n=134)
Women 91 (70) 94 (70)
Mean (SD) age (years) (range 50-98) 72.4 (12.5) 74.9 (11.9)
Mean (SD) years of education (range 0-16) 10.4 (3.8) 9.3 (3.4)
Nationality:
 Dutch 116 (89) 117 (87)
 Belgian 14 (11) 16 (12)
 Other 1 (1) 1 (1)
Living independently 115 (88) 124 (93)
Income:
 Usually enough money 61 (47) 62 (46)
 Just enough money 55 (42.) 57 (43)
 Not enough money 10 (8) 15 (11)
Cause of vision loss:
 Macular degeneration 62 (47) 60 (45)
 Glaucoma 26 (20) 19 (14)
 Cataract 26 (20) 19 (14)
 Diabetic retinopathy 5 (4) 4 (3)
 Cerebral haemorrhage 5 (4) 10 (8)
 Other 45 (34) 60 (45)
Mean (SD) years since onset (range 0-79) 16.0 (19.6) 14.4 (18.2)
LogMAR visual acuity:
 Normal visual acuity* 9 (7) 15 (11)
 Mild vision loss 24 (18) 23 (17)
 Low vision/blindness 86 (66) 86 (64)
Mean (SD) No of comorbidities (range 0-5) 1.1 (1.2) 1.2 (1.2)
History of major depressive disorder 30 (23) 25 (19)
History of dysthymic disorder 4 (3) 1 (1)
History of panic disorder 8 (6) 8 (6)
Mental health services received in three months before baseline:
 Information 14 (11) 13 (10)
 Practical support 38 (29) 34 (25)
 Skills training 5 (4) 4 (3)
 Counselling/therapy 20 (15) 17 (13)
 Referral to specialist 5 (4) 4 (3)
 Medication 17 (13) 28 (21)
*Participants with visual field of ≤30° and/or evident help request for which options in regular ophthalmic 
practice are not adequate, such as contrast sensitivity or glare.
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when needed, based on increased symptoms of depres-
sion and anxiety. In combination with usual low vision 
rehabilitation care, this seems to be a promising strat-
egy to manage depression and anxiety in this popula-
tion. It also confirms previous findings indicating that 
psychological services could be integrated in low vision 
rehabilitation care,10  14 which will increase accessibility 
of these services and enable professionals to combine 
expertise on depression and vision impairment. Nota-
bly, these results were established even though only a 
few patients needed all four steps of the programme 
and all patients were included in the analyses.
Many participants (38% of the total study popula-
tion) still developed a depressive and/or anxiety disor-
der during the course of this study. In the stepped care 
group half of these patients had a history of depressive/
anxiety disorders as opposed to 29% of the control 
group. This indicates that the stepped care programme 
was less effective for people with a history of a disorder 
and that the programme mainly prevented first  episodes 
of these disorders. The programme might therefore be 
less suitable for visually impaired patients with a his-
tory of major depressive and anxiety disorders. These 
participants might benefit from higher intensity psy-
chological interventions or pharmacotherapy.
Strengths and limitations
This study has several strengths. It shows that investi-
gating different protocol driven treatment components, 
based on successful randomisation and single mask-
ing, is feasible in studies of psychological interventions 
for people with impaired vision. Dropout rates were 
high but acceptable, and treatment fidelity was largely 
maintained. The pragmatic design of the study greatly 
enhances the generalisability of the results, which 
could lead to widespread implementation within low 
vision rehabilitation care. In contrast with previous tri-
als in low vision, we examined both depression and 
anxiety, which is relevant considering the high comor-
bidity of these disorders,5 and investigated a model for 
long term management of disease, during which sup-
port was offered only when needed based on increased 
symptoms of depression and anxiety, to maximise effec-
tiveness and efficiency. In addition, many patients were 
recognised as having subthreshold depression and/or 
anxiety or an actual disorder based on the screening 
and monitoring procedure, which otherwise might not 
have been identified. This highlights the need for such 
procedures within models of delivery of low vision care.
This study also has some limitations. Firstly, it was 
not possible to assess the specific contributions of each 
individual step of the programme. Future studies might 
choose a dismantling approach; determining redun-
dant treatment components. Secondly, selection bias 
might have occurred because patients who volunteered 
and were selected for this study might have differed 
from other eligible individuals, thereby reducing the 
generalisability of the outcomes. Responders were sig-
nificantly younger than non-responders, and partici-
pants had fewer cognitive and physical problems and 
might, for instance, have had better access to health-
care and been more motivated based on hope of per-
sonal gain. Thirdly, both low vision staff and patients 
were unmasked, which could have led to some informa-
tion bias—for instance, participants in the stepped care 
group might have had more attention on treatment out-
comes, leading to an overestimation of the results. The 
low κ coefficient for diagnosis of generalised anxiety 
disorder with the MINI could have led to overidentifica-
tion or underidentification of this disorder. In addition, 
not to overcomplicate interpretation of the secondary 
outcomes, effect estimates analysed with item response 
theory models that are increasingly used in ophthal-
mology, optometry, and low vision were not reported 
here. With these models, the effect estimates were sim-
ilarly significant, except for vision related quality of life 
(data not shown). Finally, the dropout rate was fairly 
high (34%). This was partly expected because we exam-
ined a fragile study population (elderly with a vision 
impairment and depression/anxiety) and because the 
follow-up period was longer than any previous 
table 3 | healthcare use over 24 months in intervention group (n=131; stepped care 
programme for depression and anxiety in visually impaired older adults) and control 
group (n=134; usual care). Figures are means (Sd) unless stated otherwise
intervention group  
(n=131)
Control group  
(n=134)
No of contacts with:
 General practitioner 9.4 (10.7) 9.8 (11.3)
 Company physician 0.2 (1.2) 0.2 (1.1)
 Medical specialist 10.4 (16.6) 8.4 (11.8)
 Occupational or physiotherapist 22.1 (45.1) 26.1 (42.3)
 Social worker 3.4 (8.8) 2.9 (8.2)
 Psychologist or psychiatrist 1.5 (5.1) 1.8 (6.9)
 Alternative healer 0.7 (3.8) 1.4 (5.3)
 Group based peer support 1.6 (12.6) 1.9 (13.5)
Homecare (hours) 158.8 (287.2) 154.6 (298.2)
Admission to hospital (days) 3.6 (11.4) 5.5 (17.3)
No (%) receiving medication (yes/no):
 Mental health 35 (27) 46 (34)
 Other 103 (79) 107 (80)
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Fig 2 | Kaplan-Meier survival curve for mean survival 
duration (not developing major depressive and/or anxiety 
disorder) in intervention group (n=131; stepped care 
programme for depression and anxiety in visually impaired 
older adults) and control group (n=134; usual care) with 
cumulative censoring per measurement
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 psychological intervention study performed in the spe-
cialty of low vision (seven measurements in two years). 
Dropout rates were not significantly different for the 
stepped care and control groups, indicating that the 
intervention was equally acceptable as usual care. We 
do need to realise, however, that offering psychological 
interventions in this fragile population is a challenge 
and that feasibility should have a high priority in future 
studies.
implications for practice and directions for future 
research
Our findings introduce possibilities for standard 
choices on screening, monitoring, treatment, and 
referral trajectories to deal with depression and anxi-
ety in visually impaired older adults. Patients with sub-
threshold symptoms can benefit from the (low 
intensity) psychological services offered in the stepped 
care programme that can be integrated in low vision 
rehabilitation care. In many patients only watchful 
waiting, in which problems are identified and briefly 
discussed, and the guided self help course based on 
cognitive behavioural therapy were sufficient to reduce 
depressive and anxiety symptoms. These low intensity 
and low cost interventions can fairly easily be imple-
mented in low vision rehabilitation care because of 
their accessibility (that is, people with vision impair-
ment do not have to travel), focus on empowerment, 
and low intensity of necessary resources (that is, pro-
fessional support).
In addition, screening and monitoring procedures 
should be incorporated in low vision rehabilitation care 
as detection of depression and anxiety, especially in an 
early stage of the complaints, is poor. Professionals 
(even non-mental health staff) should be made aware of 
the high prevalence and recurrent nature of these con-
ditions and patients should be stimulated to talk about 
it both at the start of rehabilitation (intake procedure) 
and during treatment as eye diseases are often degener-
ative, which can lead to depression and anxiety over 
time. Patients with a history of major depressive and 
anxiety disorders should be monitored carefully and 
offered higher intensity psychological interventions or 
pharmacotherapy because they less often benefited 
from the stepped care programme.
In a future study we will examine the costs and cost 
effectiveness of the stepped care programme compared 
with usual care. This is highly relevant in a specialty in 
which numbers of patients are vastly increasing 
(caused by demographic ageing in developed coun-
tries), and healthcare systems already have difficulty 
dealing with demand for treatment.1
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Vision related QoL (LVQOL-18) 42.6 (13.2) — — — 41.2 (12.6) — 42.1 (14.2)
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CES-D=Centre for Epidemiologic Studies Depression; HADS-A=Hospital Anxiety and Depression Scale-Anxiety; QoL=quality of life; LVQO=Low Vision 
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table 5 | patient evaluation of services in stepped care for depression and anxiety in 
visually impaired older adults. Figures are numbers (percentage) of participants unless 
stated otherwise
treatment components
guided self 
help (n=73)
problem solving 
treatment (n=29)
yes no yes no
information and participation
I received sufficient information about the method/step 52 (71) 6 (8) 20 (69) 4 (14)
I received sufficient information about the expected result 43 (59) 22 (30) 15 (52) 8 (28)
I helped determine treatment possibilities 55 (75) 10 (14) 17 (59) 6 (21)
professional
The professional had sufficient expertise 48 (66) 6 (8) 24 (83) 0 (0)
I sufficiently trusted the professional 53 (73) 5 (7) 23 (79) 1 (3)
The professional showed respect 51 (70) 6 (8) 21 (72) 2 (7)
result of the treatment*
This was the right approach for my problems 48 (66) 17 (23) 15 (52) 8 (28)
The treatment increased my feelings of control 45 (62) 20 (27) 17 (59) 6 (21)
My situation sufficiently improved based on this treatment 39 (53) 21 (29) 17 (59) 6 (21)
I am able to do more things that are important to me 35 (48) 16 (22) 21 (72) 2 (7)
I can cope better with situations that I previously had difficulty with 42 (58) 18 (25) 15 (52) 8 (28)
*Mean (SD) satisfaction score (range 4-10) was 7.5 (1.2) for guided self help and 7.0 (1.0) for problem solving 
treatment.
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